TANG CAPITAL MANAGEMENT LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 126 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
TANG CAPITAL MANAGEMENT LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2020$12,573,000
-11.7%
1,246,121
-8.7%
2.28%
+64.4%
Q2 2020$14,241,000
+110.9%
1,365,376
+70.7%
1.38%
+46.0%
Q1 2020$6,752,000
+120.9%
800,000
+129.0%
0.95%
+159.7%
Q4 2019$3,057,000
-18.7%
349,4000.0%0.36%
-43.2%
Q3 2019$3,761,000
-15.3%
349,4000.0%0.64%
+7.2%
Q2 2019$4,441,000
-67.2%
349,4000.0%0.60%
-76.0%
Q1 2019$13,553,000
+169.2%
349,400
+41.2%
2.50%
+116.2%
Q4 2018$5,035,000247,4001.16%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q1 2020
NameSharesValueWeighting ↓
HARVARD MANAGEMENT CO INC 600,000$45,216,0003.56%
Avalon Global Asset Management LLC 32,900$2,479,0001.79%
CORNERSTONE CAPITAL MANAGEMENT LLC 495,145$37,314,0001.58%
BB BIOTECH AG 521,991$39,337,0001.25%
WEATHERBIE CAPITAL, LLC 137,041$10,327,0001.20%
ADAGE CAPITAL PARTNERS GP, L.L.C. 5,686,668$428,527,0001.19%
TOBAM 318,384$23,994,0000.94%
Orbimed Advisors 1,195,500$90,093,0000.91%
Capital International Sarl 109,405$8,245,0000.74%
CAPITAL INTERNATIONAL LTD /CA/ 145,697$10,980,0000.73%
View complete list of PUMA BIOTECHNOLOGY INC shareholders